Livforsakringsbolaget Skandia Omsesidigt acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 16,394 shares of the company’s stock, valued at approximately $2,117,000.
Several other institutional investors and hedge funds also recently bought and sold shares of MKGAF. Frazier Financial Advisors LLC acquired a new position in shares of Merck KGaA in the 2nd quarter valued at about $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA during the second quarter worth approximately $27,000. Delos Wealth Advisors LLC acquired a new stake in shares of Merck KGaA during the second quarter worth approximately $33,000. Solstein Capital LLC purchased a new position in Merck KGaA during the second quarter valued at approximately $33,000. Finally, Burk Holdings LLC purchased a new position in Merck KGaA during the second quarter valued at approximately $39,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 3.8%
Merck KGaA stock opened at $164.12 on Friday. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a market cap of $21.21 billion, a PE ratio of 25.06 and a beta of 0.96. The firm’s 50 day moving average price is $163.35 and its two-hundred day moving average price is $149.06.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
